209 related articles for article (PubMed ID: 20171806)
1. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
[TBL] [Abstract][Full Text] [Related]
2. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for lymph node metastases from hepatocellular carcinoma.
Toya R; Murakami R; Yasunaga T; Baba Y; Nishimura R; Morishita S; Nishi J; Beppu T; Baba H; Yamashita Y; Oya N
Hepatogastroenterology; 2009; 56(90):476-80. PubMed ID: 19579624
[TBL] [Abstract][Full Text] [Related]
4. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
Zeng ZC; Fan J; Tang ZY; Zhou J; Wang JH; Wang BL; Guo W
Cancer Sci; 2008 Dec; 99(12):2510-7. PubMed ID: 19032365
[TBL] [Abstract][Full Text] [Related]
6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
8. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
[TBL] [Abstract][Full Text] [Related]
9. [Radiation therapy for bone metastasis from hepatocellular carcinoma].
Koom WS; Seong JS; Lee MJ; Park HC; Han KH; Chon JY; Moon YM; Suh CO
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):304-11. PubMed ID: 12499788
[TBL] [Abstract][Full Text] [Related]
10. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion.
Hou JZ; Zeng ZC; Zhang JY; Fan J; Zhou J; Zeng MS
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):362-8. PubMed ID: 22381903
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
12. Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary.
Hauswald H; Lindel K; Rochet N; Debus J; Harms W
Strahlenther Onkol; 2008 Mar; 184(3):150-6. PubMed ID: 18330511
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
Seong J; Koom WS; Park HC
Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
[TBL] [Abstract][Full Text] [Related]
15. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis.
Rim CH; Yang DS; Park YJ; Yoon WS; Lee JA; Kim CY
Jpn J Clin Oncol; 2012 Aug; 42(8):721-9. PubMed ID: 22689916
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study.
Yamashita H; Nakagawa K; Shiraishi K; Tago M; Igaki H; Nakamura N; Sasano N; Siina S; Omata M; Ohtomo K
J Gastroenterol Hepatol; 2007 Apr; 22(4):523-7. PubMed ID: 17376045
[TBL] [Abstract][Full Text] [Related]
18. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
[TBL] [Abstract][Full Text] [Related]
19. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
20. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
